Bruce S. Morra, PhD, MBA

Bruce S. Morra, PhD, MBA has more than 25 years of pharmaceutical, medical device, drug delivery, biotech and polymers industry leadership experience, and since 1998 has been a consultant and Board member to companies in these fields. He is currently on the Board of Unigene Laboratories, Inc., and BioPharm Solutions, Inc. From April 2003 through the end of 2004, Dr. Morra was President of West Pharmaceutical Services’ Drug Delivery and Contract Clinical Research businesses. After turning around the businesses, driving three products into phase II clinical trials and submitting their first formulation for regulatory approval, Dr. Morra helped orchestrate the sale of the Drug Delivery business to a leading venture capital group, Warburg Pincus. From 2002 to 2003, Dr. Morra was Chief Business Officer for Progenitor Cell Therapy, LLC, and from 1998 to 2002, he was President, COO and CFO of Biopore Corporation and its sister company Polygenetics, Inc. From 1993 to 2000 Dr. Morra served as President, COO and Founder of the drug delivery company Flamel Technologies, Inc. Dr. Morra assisted in raising venture capital funding for Flamel and taking the company public on the Nasdaq in 1996. Prior to that, Dr. Morra served as the President of ISP Filters, Inc. and held positions in General Management, Business Development, Marketing, Finance and R&D at Ausimont USA, Amoco Performance Products and E.I. DuPont. Through 1980 Dr. Morra earned his Ph.D. and M.S. in Polymer Science and Engineering and his M.B.A. from the University of Massachusetts, Ahmerst, after graduating magna cum laude in Chemical Engineering from Princeton University in 1976.